Matignon Technologies is a euro 50 million closed-end venture capital fund focused on early-stage investments in high technology companies with strong growth potential. The firm typically invests between euro 0.5 million and 3.0 million as a minority shareholder. Based in Paris, Matignon Investissement & Gestion is a registered independent financial services firm and a member of FACI & EVCA.
Notable portfolio companies include Gentis, which has raised over $20 million, Guard Medical with $11 million raised, and Glucolight with $2 million raised. Matignon Technologies is led by key partners who bring extensive experience and industry connections, offering strategic guidance and support to their portfolio companies. Their investment philosophy centers on fostering innovation and growth in high-potential tech startups.
Classification
Headquarters
1 Rue De La Faisanderie
Paris, Paris, 75116
FR
NAICS
52Finance and InsuranceEdition: 2022
523Securities, Commodity Contracts, and Other Financial Investments and Related ActivitiesEdition: 2022
5239Other Financial Investment Activities
Edition: 2022
52399All Other Financial Investment ActivitiesEdition: 2022